Prospective Case Series of Acute Complex Wounds Treated With Glyaderm

Prospective Case Series of Acute Complex Wounds Treated With Glyaderm - Glyaderm in Acute Complex Wounds

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON51082

Enrollment

Registered

2021-08-18

Start date

2021-10-25

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

deep wounds full-thickness skin and soft tissue defects

Interventions

Surgical application of Glyaderm and a split thickness skin graft in a one- or two-staged procedure.

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Age >=18 years old Acute deep dermal to full thickness skin and soft tissue defect(s) that will either not heal or take weeks to heal without grafting or (free) flap surgery

Exclusion criteria

Exclusion criteria: Active infection Severe cognitive dysfunction or psychiatric disorders in patient history Burns

Design outcomes

Secondary

Measure	Time frame
Secondary study outcomes are: - wound epithelialisation 5-7 days after STSG application; - wound closure in days after STSG application - complications: hematoma, graft loss/shift, postoperative bleeding, regrafting, wound infection; - patient and clinicians assessment of the scar after 12 weeks.	—

Primary

Measure	Time frame
The main study endpoint is graft take in the grafted wound site(s) in a total follow-up of 12 weeks.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)